Searched for: in-biosketch:true
person:drm402
Recurrent reactive infectious mucocutaneous eruption (RIME): Insights from a child with three episodes [Case Report]
Mazori, Daniel R; Nagarajan, Sairaman; Glick, Sharon A
Reactive infectious mucocutaneous eruption (RIME) was recently proposed to replace the term Mycoplasma pneumoniae (MP)-induced rash and mucositis to account for the fact that non-MP pathogens may also cause rash and mucositis. In this report, we describe a unique case of recurrent RIME featuring a total of three episodes. As two of the episodes demonstrated contemporaneous infection with MP and group A streptococcus or influenza B, this case lends further support to use of the term RIME. In addition, although RIME typically involves at least two mucous membranes, this case shows that recurrent episodes may fall into the rare exception in which mucositis is limited to one site.
PMID: 32172537
ISSN: 1525-1470
CID: 4789902
The spectrum of staphylococcal scalded skin syndrome: a case series in children [Case Report]
Mazori, D R; Leonard, A; Alexander, J B; Glick, S A
Staphylococcal scalded skin syndrome (SSSS) is a disease caused by certain toxigenic strains of Staphylococcus aureus. While the classic severe phenotype is widely recognized in children, SSSS in fact exists on a spectrum with mild and moderate variants. Misunderstanding the phenotypic spectrum of SSSS may result in misdiagnosis of an otherwise treatable condition. To increase awareness of the heterogeneity of SSSS, we report four cases that together represent a range of clinical presentations.
PMID: 31587342
ISSN: 1365-2230
CID: 4789982
Skin scores: a review of clinical scoring systems in dermatology
Mazori, Daniel R
Scoring systems are emerging in dermatology to help guide clinical decision-making. This article discusses 4 scoring systems that help prognosticate cases of Stevens-Johnson syndrome/toxic epidermal necrolysis, screen for psoriatic arthritis, differentiate cellulitis from pseudocellulitis, and determine the appropriateness of Mohs micrographic surgery (MMS).
PMID: 31675412
ISSN: 2326-6929
CID: 4789882
The ABCs of COCs: a guide for dermatology residents on combined oral contraceptives
Mazori, Daniel R
Despite the number of on-label and off-label uses for combined oral contraceptives (COCs) in dermatology, research suggests that dermatologists underprescribe COCs. With the intention of familiarizing dermatology residents with COCs, this article discusses ways to assess patient eligibility, select a COC, counsel on use, and manage risks and side effects.
PMID: 31487349
ISSN: 2326-6929
CID: 4789872
Supercharge your on-call bag: 4 must-have items for dermatology residents
Mazori, Daniel R
The contents of a dermatology resident's on-call bag can make or break their inpatient experience. This article explores 4 outside-the-box items to carry when on call (or in clinic): a hemostatic powder, antimicrobial marker, portable Wood lamp, and substitute for Michel solution.
PMID: 31039238
ISSN: 2326-6929
CID: 4789862
Delayed cutaneous reactions to iodinated contrast
Mazori, Daniel R; Nagler, Arielle R; Pomeranz, Miriam K
Iodinated contrast (IC) often is overlooked as a cause of delayed drug reactions. As a result, patients may continue to be readministered these agents, experiencing preventable morbidity. We report an illustrative case of a delayed cutaneous reaction to IC and review the literature on the epidemiology and management of this underrecognized phenomenon.
PMID: 30063771
ISSN: 2326-6929
CID: 3217072
Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment
Mazori, Daniel R; Femia, Alisa N; Vleugels, Ruth Ann
PURPOSE OF REVIEW: First recognized in 1974, eosinophilic fasciitis (EF) is a fibrosing disorder of the fascia with characteristic cutaneous and hematologic manifestations. This review discusses recent trends in the diagnosis and treatment of EF. RECENT FINDINGS: Although fascial biopsy has classically been considered the gold standard for making a diagnosis of EF, radiologic imaging, particularly magnetic resonance imaging, has been increasingly used for both diagnosis and monitoring of treatment response. Systemic corticosteroids remain the first-line treatment for EF; however, their often prolonged use in the treatment of EF has prompted a search for adjunctive therapies. Methotrexate has emerged as the leading corticosteroid-sparing agent for EF. Since EF was initially described over 40 years ago, important diagnostic and therapeutic progress has been made. Future efforts should be directed at the pursuit of prospective studies including clinical trials and evidence-based guidelines.
PMID: 29101481
ISSN: 1534-6307
CID: 2765672
Black eschars on the face and body
Callahan, Shields; Mazori, Daniel R; Femia, Alisa N
PMID: 29232425
ISSN: 2326-6929
CID: 2844392
Transformation of porokeratosis ptychotropica into invasive squamous cell carcinoma [Case Report]
Mazori, Daniel R; Shvartsbeyn, Marianna; Meehan, Shane A; Tarsis, Sara L
PMID: 28197991
ISSN: 1365-4632
CID: 2449172
Groove Sign of Eosinophilic Fasciitis
Fruchter, Renee; Mazori, Daniel R; Femia, Alisa N
PMID: 28277348
ISSN: 1536-7355
CID: 2477242